A rare case of a primary signet-ring cell carcinoma of the cervix
- Author:
Riezyl B. Culminas
1
;
Aida J. Bautista
1
;
Sabrina Ang-Sy
1
Author Information
- Publication Type:Case Reports
- Keywords: Cervical carcinoma; Cervical intraepithelial neoplasia‑1; Signet‑ring cell
- MeSH: Papanicolaou Test; Papillomavirus Infections; Carcinoma, Signet Ring Cell; Human Papillomavirus Viruses
- From: Philippine Journal of Obstetrics and Gynecology 2021;45(6):250-255
- CountryPhilippines
- Language:English
- Abstract: A 44‑year‑old woman presented with an abnormal vaginal discharge. She was initially diagnosed with cervical intraepithelial neoplasia‑1 through Papanicolaou smear and was managed with cryotherapy and completed human papillomavirus vaccinations. Nine years later, gynecologic examination showed a cervical mass, and biopsy revealed a signet‑ring cell‑type mucinous adenocarcinoma. Extensive systemic evaluation performed revealed no other malignancies. Radical hysterectomy was performed, and final pathology report showed a primary signet-ring cell cervical carcinoma stage 1B2. Concurrent chemotherapy with adjuvant external beam radiation therapy was then given. The patient has no evidence of disease for 24 months now since diagnosis. Primary signet‑ring cell carcinoma of the cervix is rare. It is diagnosed when no other tumor is found in extragenital sites, histology consists of signet‑ring morphology, tumor includes areas of adenocarcinoma in situ, and case has a prolonged survival. Overall patient education plays a vital role in management.
- Full text:PhilippJObstetGynecol456250-2313886_062538.pdf
